Want to see OTSKY full AI Analyst Report?

Otsuka Holdings Co (OTSKY) Earnings Dates, Call Summary & Reports

33 Followers

Earnings Data

Report Date

Jul 31, 2026

TBA (Confirmed)

Period Ending

2026 (Q2)

Consensus EPS Forecast

0.5

Last Year’s EPS

0.56

Same Quarter Last Year

Analyst Consensus

―

Based on 0 Analysts Ratings

Earnings Call Summary

Q2 2024

Earnings Call Date:Aug 01, 2024|

% Change Since:

Earnings Call Sentiment|Positive

The earnings call presented a strong overall performance in both pharmaceutical and nutraceutical segments with significant revenue and profit growth, and positive strategic expansions such as the acquisition for drug discovery. However, there were challenges such as impairment losses and increased SG&A expenses.

Company Guidance

During the Q2 2024 earnings call for 4578.T, significant financial growth was highlighted, with revenue increasing by 17.0% to JPY 1,108.9 billion and business profit rising by 37.8% to JPY 213.6 billion year-on-year, driven by strong performance in pharmaceutical and nutraceutical segments. Despite an impairment loss on AVP-786 affecting operating profit, net profit climbed by 5.1% due to finance income. The pharmaceutical business saw revenue increase by 17.9% to JPY 766.7 billion, bolstered by products like ABILIFY MAINTENA and JYNARQUE, while LONSURF achieved significant gains through colorectal cancer treatment guidelines endorsements. Nutraceuticals experienced over 20% growth, with revenue reaching JPY 271.8 billion, fueled by a 56.9% rise in the For Women's Health category. The company revised its full-year forecast, raising revenue expectations by JPY 175 billion to JPY 2,315 billion and business profit projections by JPY 60 billion to JPY 390 billion, aiming to maintain momentum through strategic investments and addressing social issues.

Significant Revenue and Profit Growth

Revenue increased by 17.0% to JPY 1,108.9 billion, and business profit grew by 37.8% to JPY 213.6 billion year-on-year, highlighting strong performance in pharmaceutical and nutraceutical segments.

Nutraceutical Business Expansion

The Nutraceutical business achieved over 20% growth, with revenue increasing in all three categories, notably For Women's Health at 56.9% and For Healthier Life at 25.5%.

Pharmaceutical Business Growth

Revenue in the pharmaceutical business increased by 17.9% year-on-year to JPY 766.7 billion, with significant contributions from products like REXULTI and LONSURF.

Upward Revision of Financial Forecast

The full-year revenue forecast was revised up by JPY 175 billion to JPY 2,315 billion, and business profit was revised up by JPY 60 billion to JPY 390 billion.

Acquisition for Drug Discovery

Announcement of the acquisition of a company in Boston for drug discovery technology, indicating strategic expansion.

Otsuka Holdings Co (OTSKY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OTSKY Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Play Transcript
Jul 31, 2026	2026 (Q2)	0.49 / -	0.557	―	―
Apr 28, 2026	2026 (Q1)	0.43 / 0.58	0.556	4.86% (+0.03)	―
Feb 13, 2026	2025 (Q4)	0.24 / 0.41	0.921	-55.92% (-0.52)
Oct 31, 2025	2025 (Q3)	0.52 / 0.76	0.508	50.00% (+0.25)	―
Jul 31, 2025	2025 (Q2)	0.51 / 0.56	0.187	197.86% (+0.37)
Apr 30, 2025	2025 (Q1)	0.40 / 0.56	0.453	22.74% (+0.10)	―
Feb 14, 2025	2024 (Q4)	0.42 / 0.92	-0.042	2292.86% (+0.96)	―
Oct 31, 2024	2024 (Q3)	0.63 / 0.51	0.36	41.11% (+0.15)	―
Aug 01, 2024	2024 (Q2)	0.11 / 0.19	0.267	-29.96% (-0.08)	―
Apr 30, 2024	2024 (Q1)	0.40 / 0.45	0.418	8.37% (+0.04)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OTSKY Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Apr 28, 2026	$33.25	$34.82	+4.70%
Feb 13, 2026	$32.16	$34.38	+6.91%
Oct 31, 2025	$26.56	$26.88	+1.17%
Jul 31, 2025	$24.02	$23.99	-0.12%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Otsuka Holdings Co Ltd (OTSKY) report earnings?

Otsuka Holdings Co Ltd (OTSKY) is schdueled to report earning on Jul 31, 2026, TBA (Confirmed).

What is Otsuka Holdings Co Ltd (OTSKY) earnings time?

Otsuka Holdings Co Ltd (OTSKY) earnings time is at Jul 31, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OTSKY EPS forecast?

OTSKY EPS forecast for the fiscal quarter 2026 (Q2) is 0.5.